These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21341276)

  • 21. Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats.
    Wahajuddin ; Singh SP; Raju KS; Nafis A; Puri SK; Jain GK
    Malar J; 2011 Oct; 10():293. PubMed ID: 21985153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours.
    Bae SK; Lee SJ; Kim JW; Kim YH; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 Mar; 26(2):77-83. PubMed ID: 15617135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats.
    Udeani GO; Zhao GM; Shin YG; Kosmeder JW; Beecher CW; Kinghorn AD; Moriarty RM; Moon RC; Pezzuto JM
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):263-8. PubMed ID: 11320671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
    Rajpoot P; Bali V; Pathak K
    Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats.
    Han KS; Kim YG; Yoo JK; Lee JW; Lee MG
    Biopharm Drug Dispos; 1998 Nov; 19(8):493-500. PubMed ID: 9840211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of the flavonoid quercetin in rats after single intravenous and oral doses.
    Khaled KA; El-Sayed YM; Al-Hadiya BM
    Drug Dev Ind Pharm; 2003 Apr; 29(4):397-403. PubMed ID: 12737533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects.
    Graham RA; Hop CE; Borin MT; Lum BL; Colburn D; Chang I; Shin YG; Malhi V; Low JA; Dresser MJ
    Br J Clin Pharmacol; 2012 Nov; 74(5):788-96. PubMed ID: 22458643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical assessment of the absorption and disposition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor GDC-0980 and prediction of its pharmacokinetics and efficacy in human.
    Salphati L; Pang J; Plise EG; Lee LB; Olivero AG; Prior WW; Sampath D; Wong S; Zhang X
    Drug Metab Dispos; 2012 Sep; 40(9):1785-96. PubMed ID: 22696419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated oral administration modulates the pharmacokinetic behavior of the chemopreventive agent phenethyl isothiocyanate in rats.
    Konsue N; Kirkpatrick J; Kuhnert N; King LJ; Ioannides C
    Mol Nutr Food Res; 2010 Mar; 54(3):426-32. PubMed ID: 19866468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.
    Cheng H; Leff JA; Amin R; Gertz BJ; De Smet M; Noonan N; Rogers JD; Malbecq W; Meisner D; Somers G
    Pharm Res; 1996 Mar; 13(3):445-8. PubMed ID: 8692739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent.
    Green CE; Swezey R; Bakke J; Shinn W; Furimsky A; Bejugam N; Shankar GN; Jong L; Kapetanovic IM
    Cancer Chemother Pharmacol; 2011 May; 67(5):995-1006. PubMed ID: 20623225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice.
    Clarke JD; Hsu A; Williams DE; Dashwood RH; Stevens JF; Yamamoto M; Ho E
    Pharm Res; 2011 Dec; 28(12):3171-9. PubMed ID: 21681606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic, bioavailability and tissue distribution study of astilbin in rats.
    Shi M; Xu M; Yin L
    J Pharm Pharmacol; 2020 Aug; 72(8):1061-1071. PubMed ID: 32346882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition and pharmacokinetics of phenethyl isothiocyanate and 6-phenylhexyl isothiocyanate in F344 rats.
    Conaway CC; Jiao D; Kohri T; Liebes L; Chung FL
    Drug Metab Dispos; 1999 Jan; 27(1):13-20. PubMed ID: 9884304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics and oral bioavailability studies of columbianetin in rats after oral and intravenous administration.
    Luo Q; Wang CP; Li J; Ma WF; Bai Y; Ma L; Gao XM; Zhang BL; Chang YX
    J Ethnopharmacol; 2013 Oct; 150(1):175-80. PubMed ID: 23994338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z; Tam YK; Diakur J; Wiebe LI
    J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of a novel histone deacetylase inhibitor, apicidin, in rats.
    Shin BS; Chang HS; Park EH; Yoon CH; Kim HY; Kim J; Ryu JK; Zee OP; Lee KC; Cao D; Yoo SD
    Biopharm Drug Dispos; 2006 Mar; 27(2):69-75. PubMed ID: 16299816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice.
    Ragelle H; Crauste-Manciet S; Seguin J; Brossard D; Scherman D; Arnaud P; Chabot GG
    Int J Pharm; 2012 May; 427(2):452-9. PubMed ID: 22387278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and disposition of the novel dopamine agonist Z-7760 in rat after intravenous and oral administration.
    Bollard M; Caldwell J; Taylor GW; Strolin-Benedetti M; Semeraro C
    Xenobiotica; 2000 Oct; 30(10):983-91. PubMed ID: 11315106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.